Physician profile
Mario V Mitkov
NPI 1003226051
$635.11
in general payments reported to CMS, 2019-2025
15 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $83.63 · 2021: $171 · 2024: $129 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $166.72 | 2019-2021 | |
| Kerecis Limited | $115.53 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Genzyme Corporation | $71.23 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $49.78 | 2021-2025 | Dupixent |
| Tei Medical INC. | $38.66 | 2019 | |
| Sun Pharmaceutical Industries INC. | $32.86 | 2019-2021 | |
| Janssen Biotech, INC. | $22.86 | 2025 | Tremfya, Stelara, Simponi |
| Almirall LLC | $22.60 | 2021 | |
| Organogenesis INC. | $20.69 | 2025 | Puraply Wound Matrix |
| Novartis Pharmaceuticals Corporation | $19.68 | 2019 | |
| Biofrontera INC. | $18.89 | 2025 | Ameluz |
| Genentech USA, INC. | $15.57 | 2021 | |
| Paratek Pharmaceuticals, INC. | $13.75 | 2025 | Nuzyra |
| Mimedx Group, INC. | $13.19 | 2024 | |
| Pfizer INC. | $13.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Mitkov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.